Segall Bryant & Hamill LLC Invests $1.97 Million in Viemed Healthcare, Inc. $VMD

The institutional investor acquired a new stake in the healthcare company.

Published on Mar. 6, 2026

Got story updates? Submit your updates here. ›

Segall Bryant & Hamill LLC, an institutional investor, acquired a new stake of 289,446 shares in Viemed Healthcare, Inc. (NASDAQ:VMD) during the 3rd quarter, valued at approximately $1.97 million. This represents around 0.76% ownership of Viemed Healthcare.

Why it matters

The investment by Segall Bryant & Hamill, a prominent institutional investor, signals confidence in Viemed Healthcare's growth potential and business model. As a provider of home-based respiratory therapy services, Viemed has been expanding its footprint across the U.S. to serve patients requiring long-term mechanical ventilation and pulmonary support.

The details

According to the 13F filing with the SEC, Segall Bryant & Hamill LLC acquired the 289,446 shares of Viemed Healthcare during the 3rd quarter of the year. This new stake represents approximately 0.76% ownership of the company. Other hedge funds and institutional investors have also recently added to or reduced their positions in Viemed Healthcare, indicating the stock's growing institutional interest.

  • Segall Bryant & Hamill LLC acquired the new stake in Viemed Healthcare during the 3rd quarter of the year.
  • The 13F filing with the SEC disclosing the investment was made on March 6, 2026.

The players

Segall Bryant & Hamill LLC

An institutional investment management firm that acquired a new stake in Viemed Healthcare, Inc.

Viemed Healthcare, Inc.

A provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support.

Got photos? Submit your photos here. ›

The takeaway

The investment by Segall Bryant & Hamill in Viemed Healthcare reflects the institutional investor's confidence in the company's growth potential within the home-based respiratory therapy market. As Viemed continues to expand its footprint and serve more patients across the U.S., this investment signals a positive outlook for the company's future performance.